Cotiviti Holdings (NYSE: COTV) is one of 20 public companies in the “Medical Software & Technology Services” industry, but how does it compare to its rivals? We will compare Cotiviti Holdings to similar companies based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, valuation, earnings and risk.
Risk & Volatility
Cotiviti Holdings has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Cotiviti Holdings’ rivals have a beta of 1.39, meaning that their average stock price is 39% more volatile than the S&P 500.
This is a breakdown of recent ratings and target prices for Cotiviti Holdings and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Cotiviti Holdings Competitors||84||433||820||13||2.56|
Cotiviti Holdings presently has a consensus price target of $41.29, indicating a potential upside of 29.95%. As a group, “Medical Software & Technology Services” companies have a potential upside of 20.16%. Given Cotiviti Holdings’ stronger consensus rating and higher probable upside, equities analysts plainly believe Cotiviti Holdings is more favorable than its rivals.
Earnings and Valuation
This table compares Cotiviti Holdings and its rivals gross revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Cotiviti Holdings||$625.16 million||$48.85 million||32.75|
|Cotiviti Holdings Competitors||$413.57 million||-$24.55 million||393.15|
Cotiviti Holdings has higher revenue and earnings than its rivals. Cotiviti Holdings is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This table compares Cotiviti Holdings and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Cotiviti Holdings Competitors||-14.89%||-8.49%||-0.27%|
Institutional & Insider Ownership
89.0% of Cotiviti Holdings shares are owned by institutional investors. Comparatively, 66.5% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 15.8% of Cotiviti Holdings shares are owned by insiders. Comparatively, 21.4% of shares of all “Medical Software & Technology Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Cotiviti Holdings beats its rivals on 9 of the 13 factors compared.
Cotiviti Holdings Company Profile
Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.
Receive News & Ratings for Cotiviti Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.